Healthcare Equity Learning Series Session #1: Correcting Race-Based Medicine in Chronic Kidney Disease

Join us for Session #1 of the Healthcare Equity Learning Series, “Bridging the Gap Between Health Disparities and Anti-Racist Clinical Encounters.”

According to the Centers for Disease Control and Prevention, health equity is achieved when every person has the opportunity to attain his or her full health potential and no one is disadvantaged from achieving this potential because of social position or other socially determined circumstances.

Healthcare has too often blamed marginalized communities for their poor health outcomes, not recognizing its own role in creating and perpetuating systemic inequities and biases. The purpose of this series is to examine healthcare’s role and actions in ensuring equitable care and outcomes for all patients.

This session will focus on how race, a social construct, is used as a biological indicator in the assessment, diagnosis, and treatment of kidney function and disease and how a medical student challenged this concept. We will learn the recommendations from the National Kidney Foundation (NKF) and American Society of Nephrology (ASN) task force on the inclusion of race in the estimation of GFR in the United States and its implications to chronic kidney disease diagnosis, transplant eligibility, medication impact, etc. A panel of experts will then discuss where we go from here.

Featured Speakers